Measles future or investigational therapies
|
Measles Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Measles future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Measles future or investigational therapies |
|
Risk calculators and risk factors for Measles future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Despite the impact of primary prevention with vaccination in the incidence of measles, there is still no specific antiviral treatment for the disease, once it develops. Most developing countries are still severely affected by the incidence of this conditions, due to the absence of an adequate vaccination system. Therefore it is essential the role of research in developing a more adequate approach to the disease, once it is established. Also, the development of easier and less expensive ways of bringing the vaccine to populations in developing countries would contribute to a potential eradication of measles.